Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q1

4536.TEDINET S100RJSC
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥72.4bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥279.0bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥65.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥12.8bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥8.3bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥12.9bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥5.8bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥9.1bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥10.4bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥14.9bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥6.7bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥10.4bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥6.7bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥416.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥421.2bnat 2023-03-31Cons.Assets IFRS
Total assets¥461.3bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥116.3bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥127.9bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥300.2bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥293.3bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥342.9bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥300.9bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥294.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥343.6bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥45.5bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥57.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥68.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥2.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥37.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥2.7bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥26.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥6.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥13.8bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥37.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥13.8bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥27.932023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-38.62022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥16.792022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥27.852023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-38.62022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥16.772022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio72.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.8%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 538
ItemContextValueUnit
Issuance of new shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember4000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember4000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-9000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember-7037000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember29000000JPY
Dividends ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-6009000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember170000000JPY
Other ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember185000000JPY
Other ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-185000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember4000000JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember165000000JPY
Total transactions with owners IFRSCurrentYTDDuration_TreasurySharesIFRSMember-7008000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-5825000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-185000000JPY
Equity IFRSCurrentQuarterInstant_ShareCapitalIFRSMember8707000000JPY
Equity IFRSCurrentQuarterInstant_CapitalSurplusIFRSMember9955000000JPY
Equity IFRSCurrentQuarterInstant_TreasurySharesIFRSMember-7372000000JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember242661000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember9126000000JPY
Equity IFRSPrior1YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember27971000000JPY
Equity IFRSPrior1YearInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember1562000000JPY
Equity IFRSPrior1YearInstant_ShareAcquisitionRightsIFRSMember331000000JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember37781000000JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember293979000000JPY
Equity IFRSPrior1YearInstant_NonControllingInterestsIFRSMember-683000000JPY
Equity IFRSPrior1YearInstant293297000000JPY
Profit loss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember10414000000JPY
Profit loss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-2000000JPY
Profit loss IFRSCurrentYTDDuration10412000000JPY
Other comprehensive income IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember7245000000JPY
Other comprehensive income IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember749000000JPY
Other comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember9388000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember9388000000JPY
Other comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-22000000JPY
Other comprehensive income IFRSCurrentYTDDuration9366000000JPY
Comprehensive income IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember7245000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember749000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember9388000000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember19802000000JPY
Comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-24000000JPY
Comprehensive income IFRSCurrentYTDDuration19778000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember-9000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-9000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember0JPY
Issuance of new shares ss IFRSCurrentYTDDuration0JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass